LD2D.4

ICD-11 MMS 2026-01

Gorlin syndrome

Description

Gorlin syndrome, also known as naevoid basal cell carcinoma syndrome (NBCCS), is a hereditary condition characterised by a wide range of developmental abnormalities (odontogenic keratocysts of the jaws, hyperkeratosis of palms and soles, skeletal abnormalities, intracranial ectopic calcifications, and facial dysmorphism) and a predisposition to develop malignant neoplasms (such as multiple basal cell carcinomas or medulloblastoma), and benign neoplasms in the jaw, heart, or ovaries.

Index terms

  • Gorlin syndrome
  • NBCCS - [Naevoid basal cell carcinoma syndrome]
  • Naevoid basal cell carcinoma syndrome

Inclusions

  • Naevoid basal cell carcinoma syndrome

Exclusions from above levels

  • 2E83.Z – Enchondromatosis
  • 4A01.31 – Ataxia-telangiectasia
  • 8C21.1 – familial dysautonomia [Riley-Day]
Show allHide
  • LA90.00 – Rendu-Osler-Weber disease
  • LD23 – Sturge-Weber syndrome
  • LD26.60 – Angio-osteohypertrophic syndrome
  • LD2C – Proteus syndrome
  • LD2F.1Y – Maffucci syndrome
  • http://id.who.int/icd/entity/733825440 – Inborn errors of metabolism

Sibling codes

  • LD2D.0 – Peutz-Jeghers syndrome
  • LD2D.1 – Neurofibromatoses
  • LD2D.2 – Tuberous sclerosis
  • LD2D.3 – Gardner syndrome
  • LD2D.Y – Other specified phakomatoses or hamartoneoplastic syndromes
  • LD2D.Z – Phakomatoses or hamartoneoplastic syndromes, unspecified

Foundation entity

Gorlin syndrome – http://id.who.int/icd/entity/1012745138

Part of: LD2D: Phakomatoses or hamartoneoplastic syndromes › 20: Developmental anomalies